{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-245602","form_type":"8-K","ticker":"TCRT","cik":"0001107421","company_name":"Alaunos Therapeutics, Inc.","filed_at":"2023-09-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.154272+00:00","generated_at":"2026-06-10T07:24:23.280955+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Alaunos Therapeutics Chairman James Huang resigns; Holger Weis elected successor","bullets":["James Huang resigned as Chairman and board member effective September 22, 2023.","Resignation not due to any disagreement on operations, policies, or practices.","Board elected Holger Weis as new Chairman of the Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-245602","json":"https://secwatch.observer/filing/0001193125-23-245602.json","markdown":"https://secwatch.observer/filing/0001193125-23-245602.md","text":"https://secwatch.observer/filing/0001193125-23-245602.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1107421/000119312523245602/0001193125-23-245602-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1107421/000119312523245602/d469943d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T07:24:23.280955+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"40cd4acb4a","claim":"Holger Weis was elected as Chairman at Alaunos Therapeutics, Inc..","evidence_excerpt":"With Mr. Huang’s departure, the Board has elected Holger Weis as the Company’s new Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312523245602/0001193125-23-245602-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Chairman"}],"fact_type":"executive_change"},{"claim_id":"5d694a01da","claim":"James Huang resigned as Chairman at Alaunos Therapeutics, Inc..","evidence_excerpt":"On September 22, 2023, James Huang resigned as Chairman and member of the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) with immediate effect in order to focus on other business pursuits.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312523245602/0001193125-23-245602-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}